Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 years later Dec 31, 2025 → Dec 31, 2034
See other at-risk trials from Francesco De Cobelli

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 31, 2025 to Dec 31, 2034
    • Study completion pushed from Dec 31, 2030 to Dec 31, 2039
    • Eligibility criteria expanded, about 7 words
    • Publications: details revised at 2 of 2 entries
  2. Re-verified, no change to tracked fieldsv5
  3. Study description expanded, about 86 wordsv4
  4. Enrollment target: 250 to 500
    • Primary completion date: Feb 28, 2024 to Dec 31, 2025
    • Study completion date: Feb 28, 2024 to Dec 31, 2030
    v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to collect data on efficacy and safety of microwave ablation (MWA) used to treat subjects with primary and secondary liver malignancies and renal malignancies. The main question it aims to evaluate the short, medium and long-term clinical course of patients treated with MWA. Participants will not alter their normal clinical and therapeutic practice, due to the observational nature of the study, and all data regarding microwave treatments will be collected (including demographic data). follow their normal clinical and therapeutic path
Trial Details
NCT Number NCT03981497
Lead Sponsor Francesco De Cobelli
Conditions
(from sponsor)		 Liver Cancer, Liver Metastasis Colon Cancer, Kidney Cancer, Renal Cell Carcinoma
Related terms Carcinoma, Renal Cell, Kidney Neoplasms, Liver Neoplasms
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov